Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

528.58 5.19 −0.97%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation 10-K filed Feb 27, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 9:36 AM ET · Document on sec.gov · Filing index

Red flags

  • Restatement

    Chemed Corporation’s 10-K corrects an error in previously issued financial statements

    10-K filed · The filing · sec.gov

What changed

Item 1A, Risk Factors, against the 10-K filed Feb 28, 2025: 14 added · 1 removed · 14 modified